Related references
Note: Only part of the references are listed.Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
Delphine Merino et al.
BLOOD (2012)
The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2
Gemot Polier et al.
CHEMISTRY & BIOLOGY (2012)
Drug resistance: Still a daunting challenge to the successful treatment of AML
Brian C. Shaffer et al.
DRUG RESISTANCE UPDATES (2012)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A tumour suppressor network relying on the polyamine-hypusine axis
Claudio Scuoppo et al.
NATURE (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
Identification of Global Alteration of Translational Regulation in Glioma In Vivo
Karim Helmy et al.
PLOS ONE (2012)
A cellular response linking eIF4AI activity to eIF4AII transcription
Gabriela Galicia-Vazquez et al.
RNA (2012)
Genome Sequencing Identifies a Basis for Everolimus Sensitivity
Gopa Iyer et al.
SCIENCE (2012)
Emerging Therapeutics Targeting mRNA Translation
Abba Malina et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis
Chen-Ju Lin et al.
CELL REPORTS (2012)
Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells
Sneha V. Gupta et al.
AAPS JOURNAL (2011)
Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia
Tomoyuki Tsumuraya et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis of the Antiproliferative Agent Hippuristanol and Its Analogues via Suarez Cyclizations and Hg(II)-Catalyzed Spiroketalizations
Kontham Ravindar et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F
Regina Cencic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
Nina Ilic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Derek Yecies et al.
BLOOD (2010)
Pdcd4, a colon cancer prognostic that is regulated by a microRNA
Heike Allgayer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
Meike Vogler et al.
BLOOD (2009)
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
David M. Lucas et al.
BLOOD (2009)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Expeditious Synthesis of Hippuristanol and Congeners with Potent Antiproliferative Activities
Wei Li et al.
CHEMISTRY-A EUROPEAN JOURNAL (2009)
SUnSET, a nonradioactive method to monitor protein synthesis
Enrico K. Schmidt et al.
NATURE METHODS (2009)
Altering Chemosensitivity by Modulating Translation Elongation
Francis Robert et al.
PLOS ONE (2009)
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Regina Cencic et al.
PLOS ONE (2009)
BH3 mimetic ABT-737 potentiates TRAIL-mediated apoptotic signaling by unsequestering bim and bak in human pancreatic cancer cells
Shengbing Huang et al.
CANCER RESEARCH (2008)
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
Ozgur Kutuk et al.
CANCER RESEARCH (2008)
Translational control by a small RNA: Dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism
Daisy Lin et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Selective Pharmacological Targeting of a DEAD Box RNA Helicase
Lisa Lindqvist et al.
PLOS ONE (2008)
mTORC1 promotes survival through translational control of Mcl-1
John R. Mills et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dissecting eIF4E action in tumorigenesis
Hans-Guido Wendel et al.
GENES & DEVELOPMENT (2007)
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
James Witham et al.
CLINICAL CANCER RESEARCH (2007)
Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer
Giridhar Mudduluru et al.
CANCER (2007)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4
Anja Hilliard et al.
JOURNAL OF IMMUNOLOGY (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo
Hans-Guido Wendel et al.
CANCER RESEARCH (2006)
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
ME Bordeleau et al.
NATURE CHEMICAL BIOLOGY (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells
A Cuconati et al.
GENES & DEVELOPMENT (2003)
Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to Polysomes
VK Rajasekhar et al.
MOLECULAR CELL (2003)
Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
D Nijhawan et al.
GENES & DEVELOPMENT (2003)
MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis
RW Craig
LEUKEMIA (2002)
Share Paper
